© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Rhett Wilkerson, associate director of patient financial services, Florida Cancer Specialists, discusses financial toxicity in cancer care.
Transcript
So that is something that, as deductibles and out-of-pockets continue to rise, is something that is prevalent. Being able to be aggressive about reaching out finding copay assistance or foundations or grants that are appropriate for the patient is one way that, you know, we work to alleviate that.
But then also, again, knowing those drug costs and being able to put together successful payment plans that cover, you know, the cost of the drug, and kind of looking at the whole episode of care to really make an aggressive payment plan that fits, that's something that the patient can make and then also covers the cost of the drug.